ghk-cu peptide injection research GHK‑Cu Copper Therapy GHK-CU – Research Peptide |

7 patients with chronic pain such as migraines, vasomotor headaches, chronic tinnitus and also psychogenic panic attacks and depressive states participated in the study of the therapeutic effects of DSIP

As a result, I view Epithalon as a promising investigational therapy rather than a proven longevity intervention

In clinical wound-care settings, adjunct topical GHK-Cu gels were associated with larger median reductions in ulcer area and fewer recorded wound infections relative to standard care alone, particularly in larger plantar lesions that were slower to progress under routine protocols

3-5 Days (aprox to Major Centres

Allowing the sealed vial to equilibrate to room temperature

Purity: 99% (HPLC verified)